StonvexLoading…
StonvexStonvexStonvexCore line items from BILI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.34B | $3.68B | $3.17B | $3.18B |
Operating Income | $160.79M | $-184.12M | $-713.27M | $-1.21B |
Net Income | $170.67M | $-1.35B | $-4.82B | $-1.09B |
EPS (Diluted) | $0.39 | $-0.44 | $-1.64 | $-2.75 |
Total Assets | $5.89B | $4.48B | $4.67B | $6.06B |
Total Liabilities | $3.66B | $2.55B | $2.64B | $3.86B |
Cash & Equivalents | $1.74B | $1.40B | $1.01B | $1.47B |
Free Cash Flow OCF − CapEx | $948.68M | $760.28M | $11.93M | $-677.35M |
Shares Outstanding | Not available | Not available | Not available | Not available |